Bristol-Myers Squibb (BMY) Stock Price, Quote, News & History | Benzinga

Bristol-Myers Squibb Co (BMY) Stock Price, Quote, News & History

BMYNYSE

Trade with Public

Trade with Public

$62.96

0.340.55%

Last update: Sep 22, 9:05 AM

Dividend: The dividend Ex-Date is in 10 days

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$62.73

Close

-

Volume / Avg.

1.19M / 11.48M

Day Range

$62.03 - $63.08

52 Wk Range

42.52 - 68.64

Market Cap

$128.61B

P/E Ratio

13.79

Dividend Yield

4.02%

Exchange

NYSE

RSI

41

Short Interest

2.16%

Days to Cover

5.27

Recent Bristol-Myers Squibb Company News

This $3 Biotech Could Be Worth $11.45, Analyst Says

William Blair initiates Perspective Therapeutics (NYSE: CATX) at Outperform, citing its strong radiopharmaceutical platform.

Vandana Singh

Bristol Myers Squibb’s Psoriatic Arthritis Pill Shows Durable Efficacy After Two Years

Bristol Myers Squibb (BMY) 2-year Phase 3 data shows Sotyktu maintains durable efficacy and safety in active psoriatic arthritis.

Vandana Singh

Bristol Myers Says Cell Therapy Shows Promise For Heavily Pretreated Blood Cancer Patients

Bristol Myers Squibb reported positive Phase 2 results for its arlo-cel therapy, meeting key endpoints for multiple myeloma patients.

Vandana Singh

A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths

Novartis and Bristol Myers pause CAR-T autoimmune trials after patient deaths and severe side effects spark safety concerns.

Vandana Singh

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

12.78B

Investing Cash Flow (TTM)

-4.91B

Financing Cash Flow (TTM)

-11.71B

Free Cash Flow (TTM)

11.44B

Capital Expenditure (TTM)

-1.34B

Net Change in Cash (TTM)

-3.83B

Analyst Trends and Forecast

2

1

Apr

4

3

Jul

1

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$161.90B

PE Ratio (TTM)

13.79

PE Ratio (FWD)

9.59

PEG Ratio (TTM)

17.44

PS Ratio (TTM)

2.60

PB Ratio (TTM)

5.73

Earnings Yield % (TTM)

7.25%

Earnings Yield % (FWD)

10.43%

EV / EBITDA (TTM)

9.63

Price / EBITDA (TTM)

7.61

Price / Free Cash Flow (TTM)

11.19

Book Value / Share

$10.93

Company Debt

Total Debt

$43.12B

LT Debt

$42.09B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$12.02B

Total Cash

$8.72B

Debt to Equity

2.02

Issuance of Debt (TTM)

-$6.28B

Repayment of Debt (TTM)

-$12.02B

Key Statistics

Open

$62.73

Close

-

Volume / Avg.

1.19M / 11.48M

Day Range

$62.03 - $63.08

52 Wk Range

42.52 - 68.64

Market Cap

$128.61B

P/E Ratio

13.79

Dividend Yield

4.02%

Exchange

NYSE

RSI

41

Short Interest

2.16%

Days to Cover

5.27

About

Sector

Health Care

Industry

Pharmaceuticals

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Bristol-Myers Squibb (BMY) stock?

A

You can purchase shares of Bristol-Myers Squibb (NYSE:BMY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bristol-Myers Squibb (BMY) competitors?

A

Other companies in Bristol-Myers Squibb’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Bristol-Myers Squibb (BMY) stock?

A

Bristol-Myers Squibb has a consensus price target of $61.87.

Q

What is the current price for Bristol-Myers Squibb (BMY)?

A

The stock price for Bristol-Myers Squibb (NYSE: BMY) is $62.9613 last updated September 22, 2026 at 9:05 AM EDT.

Q

Does Bristol-Myers Squibb (BMY) pay a dividend?

A

There are no upcoming dividends for Bristol-Myers Squibb.

Q

When is Bristol-Myers Squibb (NYSE:BMY) reporting earnings?

A

Bristol-Myers Squibb does not have any upcoming earnings scheduled.

Q

Is Bristol-Myers Squibb (BMY) going to split?

A

There is no upcoming split for Bristol-Myers Squibb.

Q

What sector and industry does Bristol-Myers Squibb (BMY) operate in?

A

Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.